Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,822 | 2,208 | 2,482 | 3,779 | 3,989 |
| Cost of Goods | 1,555 | 3,367 | 1,660 | 2,367 | 2,374 |
| Gross Profit | 1,267 | -1,159 | 822 | 1,412 | 1,615 |
| Operating Expenses | 17,376 | 76,524 | 22,833 | 29,108 | 30,136 |
| Operating Income | -15,554 | -77,316 | -21,351 | -27,329 | -28,147 |
| Interest Expense | 301 | 0 | 0 | 0 | 0 |
| Other Income | 1,642 | -1,460 | 6,412 | 7 | 172 |
| Pre-tax Income | -14,213 | -78,776 | -14,939 | -27,322 | -27,975 |
| Net Income Continuous | -14,213 | -78,776 | -14,939 | -27,322 | -27,975 |
| Net Income | $-14,213 | $-78,776 | $-14,939 | $-27,322 | $-27,975 |
| EPS Basic Total Ops | -22.68 | -1,920.85 | -535.72 | 4,321.34 | -3,863.00 |
| EPS Basic Continuous Ops | -22.68 | -1,920.85 | -535.72 | 4,334.21 | -3,862.94 |
| EPS Diluted Total Ops | -22.68 | -1,920.85 | -535.72 | 4,321.34 | -3,863.00 |
| EPS Diluted Continuous Ops | -22.68 | -1,920.85 | -535.72 | 4,334.21 | -3,862.94 |
| EPS Diluted Before Non-Recurring Items | -23.00 | -1,928.00 | -575.08 | N/A | N/A |
| EBITDA(a) | $-14,835 | $-75,982 | $-19,839 | $-26,068 | $-26,931 |